Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

Introduction: Survival of ALK-rearranged NSCLC patients has dramatically improved by the use of multiple ALK-tyrosine kinase inhibitors (ALK-TKI). However, still little is known about the impact of drug sequencing and clinical features on survival in a real-world setting.Methods: Patients with stage...

Full description

Bibliographic Details
Main Authors: Christian Britschgi, Alfredo Addeo, Markus Rechsteiner, Raphaël Delaloye, Martin Früh, Giulio Metro, Marco Banini, Oliver Gautschi, Sacha I. Rothschild, Peter J. Wild, Giuseppe L. Banna, Alessandra Curioni-Fontecedro
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
real world data
NSCLC
targeted therapy
overall survival
ALK-rearranged non-small cell lung cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01299/full

Similar Items

Similar Items